Provided by Tiger Trade Technology Pte. Ltd.

Burning Rock Biotech Limited

19.45
+2.8517.17%
Post-market: 19.450.00000.00%16:40 EST
Volume:92.67K
Turnover:1.71M
Market Cap:209.41M
PE:-10.48
High:19.50
Open:16.80
Low:16.80
Close:16.60
52wk High:19.50
52wk Low:2.18
Shares:10.77M
Float Shares:4.83M
Volume Ratio:1.45
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8560
EPS(LYR):-4.6135
ROE:-20.25%
ROA:-6.23%
PB:2.70
PE(LYR):-4.22

Loading ...

Stock Track | Burning Rock Biotech Plummets 8.22% on Disappointing Q3 Results and Revenue Declines

Stock Track
·
Nov 21

Stock Track | Burning Rock Biotech Plummets 8.22% Following Q3 Results and Ongoing Business Transition

Stock Track
·
Nov 21

Stock Track | Burning Rock Biotech Soars 6.05% Pre-Market on Strong Q3 Results and Narrowed Losses

Stock Track
·
Nov 20

Burning Rock Biotech Limited Q3 Adjusted Gross Margin 76.7%

THOMSON REUTERS
·
Nov 20

Burning Rock Biotech Limited Q3 Net Income RMB -16.8 Million

THOMSON REUTERS
·
Nov 20

Burning Rock Biotech Limited Q3 Revenue RMB 131.6 Million

THOMSON REUTERS
·
Nov 20

Burning Rock Biotech Limited Q3 Operating Expenses RMB 115 Million

THOMSON REUTERS
·
Nov 20

Burning Rock Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 20

Burning Rock Biotech Ltd. posts Q3 revenue of RMB 131.6 million

Reuters
·
Nov 20

Stock Track | Burning Rock Biotech (BNR) Soars 5.13% Pre-market, Extending 60% Rally on Strong Research and Financial Progress

Stock Track
·
Oct 28

Stock Track | Burning Rock Biotech (BNR) Surges 5.04% Pre-market, Extending Recent Rally on Positive Developments

Stock Track
·
Oct 28

Burning Rock Biotech (BNR.US): After 2 Months of Sideways Trading, "Five Consecutive Gains" Emerge with 60% Surge—Profitability Expectations Take Center Stage

Stock News
·
Oct 28

Bulletin Resources Limited Announces Date for Annual General Meeting

TIPRANKS
·
Sep 25

Bulletin Resources Releases 2025 Corporate Governance Statement

TIPRANKS
·
Sep 25

Burning Rock announces OncoGuide OncoScreen Plus CDx System approval in Japan

TIPRANKS
·
Sep 24

Burning Rock's Oncoguide™ Oncoscreen™ Plus Cdx System NOW Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

THOMSON REUTERS
·
Sep 24

Burning Rock Biotech Ltd. and Riken Genesis Secure Japan's Approval for OncoScreen™ Plus CDx System as Companion Diagnostic for Breast Cancer Treatment

Reuters
·
Sep 24

Stock Track | Burning Rock Biotech Soars 7.83% on Strong Q2 Results and Narrowed Losses

Stock Track
·
Sep 08

Stock Track | Burning Rock Biotech Soars 7.83% as Q2 Results Show Narrowing Losses and Revenue Growth

Stock Track
·
Sep 08

Stock Track | Burning Rock Biotech Soars 6.14% on Strong Q2 Results and Reduced Losses

Stock Track
·
Sep 08